Fundamentals data is not available for this company.
No recent information was found.
Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
Currency | US Dollars |
Share Price | $ 30.52 |
Change Today | $ -1.14 |
% Change | -3.60 % |
52 Week High | $36.00 |
52 Week Low | $23.01 |
Volume | 462,687 |
Shares Issued | 156.88m |
Market Cap | $4,788.05m |
RiskGrade | 248 |
Time | Volume / Share Price |
11:08 | 101 @ $30.52 |
11:08 | 100 @ $30.52 |
11:08 | 100 @ $30.50 |
11:08 | 199 @ $30.52 |
11:08 | 100 @ $30.49 |
You are here: research